FDA Considering Regulation for mHealth Mobile Health Applications

OPEN MINDS Weekly News Wire Strategic Health Care News The U.S. Food and Drug Administration (FDA) has been considering how and when to regulate mobile health applications that are used on wireless phones without altering the phone’s primary function as a mobile telecommunication device. These mobile devices—such as cell phones, PDAs, and other wireless technologies—used to collect health data and transmit that information between medical personnel are considered to be forms of mobile health, or mHealth. The director of the FDA Center for Device and Radiological Health has testified to Congress that the agency has the . . .